New shot aims to stop pancreatic cancer from spreading
NCT ID NCT05634720
Summary
This study is testing if a single dose of chemotherapy delivered directly to the liver artery is safe and practical for people with pancreatic cancer who are scheduled for surgery. The goal is to see if this extra step, given before the standard surgery and chemo, can help control the disease and prevent it from spreading to the liver. The trial includes 20 patients and will monitor them for safety and long-term outcomes like survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Health System
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.